Join BOPA
Back to news articles

CRUK Consent Form Updates – MPN and Nivolumab with Relatlimab for melanoma

By BOPA Executive Committee on 4th November 2024

Dear All,

I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added  form for Nivolumab with Relatlimab for melanoma.

All forms can be found here: www.cruk.org/sact_consent.

Please share this update with your clinical teams or forward to the appropriate lead cancer clinician in your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam (she/her)

Specialist Oncology Pharmacist, CRUK Information Lead

Latest News

By BOPA Committee on 26th November 2024

ISOPP CAPhO Symposium 2025 – Register Now!

Join the International Society of Oncology Pharmacy Practitioners and the Canadian Association of Pharmacy Oncology for leading edge education to advance your oncology pharmacy practice and knowledge! The ISOPP CAPhO Symposium 2025 will take…

Read article
By BOPA Executive Committee on 25th November 2024

Announcement: New Specialist pancreatic cancer E-Learning Resource Now Available

Announcement: New Specialist pancreatic cancer E-Learning Resource Now Available We’re excited to announce that a new specialist e-learning resource has been added to our website! This invaluable resource, provided by…

Read article
By BOPA on 23rd November 2024

New Recordings NOW available

The recordings of the UK BMT Pharmacists Group Educational Meeting June 2024 is now available to watch via this link: UK BMT Pharmacists Group Educational Meeting Series (June 2024)  …

Read article
By BOPA Research Committee on 21st November 2024

National survey about the implementation of JBDS/UK chemo board guidelines on the management of glycaemia in people with cancer

National survey about the implementation of JBDS/UK chemo board guidelines on the management of glycaemia in people with cancer. The purpose is to understand some of the enablers and barriers…

Read article